12 - 02 - 2010
Muntons Malted Ingredients are pleased to announce the strengthening of their existing relationship with Barentz Group Europe, with the signing of a new Distribution Agreement this week. Barentz Group currently represent Muntons Malted Ingredients in France and Italy in the bakery & food markets and the new agreement expands representation into Belgium, Bulgaria, Czech Republic, The Netherlands, Luxembourg, Poland and Romania. James Smith, European Sales Manager of Muntons Malted Ingredients is confident that the widening of Barentz Group’s coverage for Muntons in Europe will bring many positive rewards: “We have been working with Barentz for several years and our customers in France and Italy have been very happy with the level of reliability and support that has been brought to our business relationships.” Andrew Suett, Malted Ingredients Sales and Marketing Director at Muntons added, “We expect Barentz to bring this high standard of service to both new and existing customers across Europe. With our excellent product range and Barentz’s great customer knowledge we expect this important strategic relationship to deliver increased business to both Companies and allow them to realise their potential in these expanding ingredients markets. Barentz already have strong links within the food industry where our malted ingredients can be used extensively: in baking; confectionary; breakfast cereals and many other areas to add texture flavour and colour to finished products. We feel that our products fit in well with the products that Barentz currently supply and anticipate that the addition of our range of ingredients can only make Barentz’s portfolio more appealing; allowing us to reach customers in areas which may previously have been inaccessible for us.” Geert Ingelbert, VP Food Division of the Barentz Group declares: “The products supplied by Muntons Malted Ingredients provide our customers with true solutions for the food industry that is looking for more cost effective and clean label solutions and these products fit completely in our offering of ingredients and additives. The excellent application know how of Muntons Malted Ingredients is complemented by our own Centres of Excellence. We believe that together we can provide our customers with the optimal service and support to realize our common goals.” About Muntons plc Muntons plc is a BRC and ISO: 9001/2008, ISO 14001:2004 and ISO 22000:2005 accredited malting company which is privately owned and is Europe’s biggest supplier of Malted Ingredients to the bakery, confectionary, pharmaceutical, brewing and distilling industries. Based at two sites in England and with offices in the USA and Singapore, Muntons plc 2008 turnover was £72 million. MMI Inc: We have incorporated a new US company under the name of Muntons Malted Ingredients Inc, with the sales office being based close to Seattle in Bellevue Washington, USA. About Barentz Europe Barentz Europe is a privately owned company and one of the leading speciality raw material companies in Europe active with more than 400 people in 28 countries. The company is active in distribution towards the food, feed, pharmaceutical & cosmetic and chemical industries. The turnover of The Barentz Group in 2008 amounted to €544 million.
11 - 02 - 2010
March 23–25 the Food Ingredients China 2010 will be organized in the Shanghai Everbright Convention and Exhibition Centre (SECEC) in China. FIC is the largest food additives & ingredients trade fair in Asia. Barentz will participate in this fair. Please come and visit us at BOOTH# 2C26. Our Sourcing team will be delighted to meet you there. For any further information or appointments please contact our Changzhou office at +86–519–6683106 or mail to sourcing@barentz.com.
26 - 01 - 2010
Nine companies and universities have joined forces in combating obesity. They will develop and produce healthy food products and ingredients that are rich in protein, and then introduce these in properly monitored diet programmes. To determine individual diet prescriptions, a test based on biomarkers will be developed. Many inhabitants in the east of the Netherlands are overweight. Obesity increases the chances of heart and coronary diseases, joint problems, some types of cancer and other diseases. It also leads to above average sickness absenteeism at the workplace, which in turn requires higher healthcare costs. By combining forces in knowledge and know-how in the area of ‘Food, Health and Technology’ which are present in this region, these problems can be tackled effectively and efficiently. In combating obesity, even a little weight loss could already lead to an improvement in health and welfare. Sickness absenteeism will be reduced due to an improved health status of employees. This project would also give rise to more local employment opportunities and, therefore, improve the economic standing of this region. In this project Wageningen UR (Food & Biobased Research institute and division of Human Nutrition), Previtas, Newtricious, Ollyxa, Molecular Nanofabrication group – University of Twente, Nijmegen Proteomics & Metabolomics Facilities – UMC St Radboud, Zwanenberg Food Group, Barentz Ingredients en Zijerveld have joined forces. The project is part of the programme ‘Pieken in de Delta-Oost Nederland’ subsidized by the Ministry of Economic Affairs and the Gelderland and Overijssel provinces, The Netherlands. More information: Erika van Gennip Tel: + 31 317 480 701 Email: erika.vangennip@wur.nl www.eiwittegenovergewicht.org/uk
01 - 10 - 2009
On September 23rd we received the sad news that our founder Mr. Herman Barentz has passed away quietly at the age of 86. In 1953 Mr. Barentz founded his company Barentz Chemische Grondstoffen in Amsterdam. During the first 20 years he managed the company and built the foundation of the current enterprise. Since the seventies he has put professional management in charge of the company and throughout the years the company enjoyed steady growth. In 1989 the first foreign subsidiary was opened and since the turn of the century Barentz has continued to execute a truly pan-European strategy. In 1990 the company moved the head office from downtown Amsterdam to the current location in Hoofddorp. The company changed its name to Barentz Raw Materials on the one hand to do justice to the internationalization and on the other hand to stress that the company is active in many fields and notably has a leading role in the distribution of food ingredients and additives, as well as ingredients for animal nutrition, pharmaceutical and cosmetic industries, as well as products for the chemical industries. At the half century jubilee celebrations of the company Mr. Barentz decided to confine his shares to a foundation that would assure the continuity and independence of the company for the future. Today there are 23 companies in Europe and China that bear the Barentz name and the company employs over 400 people. Although the company has been managed by independent professionals for many years, Mr. Barentz always followed the company closely until the very end. He had the unique ability to learn from the past, but most of all look ahead. Putting the customer at the heart of our thinking and actions and from there looking for the next possible deal, was the fundamental lesson he had for us. He will continue to be a lasting source of inspiration to us all. Hidde van der Wal, Chief Executive Officer Barentz Europe BV
01 - 09 - 2009
Vitablend in Wolvega, Barentz Ingredients in Almelo and L.I. Frank in Twello together form the Production Division of Barentz Europe. In order to accommodate the growth of Vitablend and Barentz Ingredients, the production of both companies will be centralized in Wolvega over the next few months. By combining both locations better opportunities for growth are created and the Centers of Excellence for food, pharma and nutrition can be combined and reinforced. All of the companies technologists will be working together in the brand new application and pilot facilities in Wolvega. Currently 22 people are working in Almelo and they will all be offered the opportunity to move along to the new site in Friesland. The company will facilitate the relocation of all employees. Vitablend was formed in 2000 and has a state-of-the-art facility in Wolvega, in the province of Friesland in The Netherlands. The company is a specialist in protection, with a full range of antioxidant products, and in fortification, through tailor made blends of micronutrients, such as vitamins, minerals, amino acids, nucleotides and nutraceuticals. The company offers a vast know how in food and pharmaceutical applications from infant to clinical nutrition to food supplements and from spreads to baked goods, cereals and drinks. Vitablend has its own sales offices in France, Germany and the UK. Barentz Ingredients exists 20 years and became part of the Barentz group of companies in 2002. The company is a specialist in functional blends focusing on yield, texture and protection of meat and fish products. In combination with L.I. Frank, Barentz Ingredients also offers specialty blends for the fine bakery industry such as the wafer, puff pastry and biscuit industry focusing on health benefits, clean label and shelf life extension. Barentz Europe is a specialized distribution company for the food, feed, pharmaceutical, cosmetic and chemical industries. The company had a turnover of € 545 Million in 2008 and just over 400 employees. Centers of Excellence with ownership of technology are a key part of Barentz growth strategy. “By combining these two production locations, we create significant synergies and will be much better prepared to deal with our continued growth .” says Jack Boers, the director of Vitablend. “Vitablend’s expertise in developing and producing Protection and Fortification systems and Barentz Ingredients expertise in bakery and meat applications, will accelerate our product development. This will lead to new exiting products and solutions for our customers.” “Our centers of excellence in pharma, bakery, meat and nutritional products have demonstrated their value in bringing innovative and technological support to our customers.” according to Hidde van der Wal, CEO of Barentz Europe BV. “We continue to investment in our production division, as we believe them to be a corner stone in our continued growth of the group.” Contacts: Barentz: Rinus Heemskerk, +31 23 567 3456 Vitablend/Barentz Ingredients: Jack Boers, + 31 561 69 1831

Latest News

06 - 02 - 2020
Barentz international B.V. and Matco Foods Limited officially announce the start of a new Joint Venture in Pakistan, following agreement between both parties. The aim of the new activity is to better serve the rapidly growing Pakistani food processing market with a target group of 200 million citizens. Matco Foods has built up an extended network within the Pakistan local food industry Barentz International offers the broadest high-quality ingredients portfolio within the global life science markets Barentz Pakistan will primarily focus on the markets for Human Nutrition and Pharmaceutical products
26 - 11 - 2019
Barentz announces today that Cinven has agreed to invest in their company. Cinven is a leading international private equity firm focused on building world-class European and global companies. Barentz has a strong market position in a structurally growing market for life science ingredients The Cinven team knows the speciality ingredients distribution market well Cinven recognizes the opportunities for both organic and buy and build growth Financial terms of the transaction are not disclosed  
04 - 11 - 2019
Barentz, a leading distributor of ingredients in the life science markets, is pleased to announce it has acquired a majority shareholding in Czech Republic based IMCoPharma. Highlights: IMCoPharma is a leader in the pharmaceutical ingredients market in the CIS region and Ukraine Both Barentz and IMCoPharma are known for their deep technical knowledge and broad portfolio of pharmaceutical ingredients This strategic investment provides Barentz with the licensing capability to do business with all pharmaceutical companies in this attractive region IMCoPharma considers this acquisition as an opportunity for strengthening its position in this market and creating new opportunities